Loading…
Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attr...
Saved in:
Published in: | bioRxiv 2020-11 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | |
container_start_page | |
container_title | bioRxiv |
container_volume | |
creator | Mehalko, Jennifer Drew, Matthew Snead, Kelly Denson, John-Paul Wall, Vanessa Taylor, Troy Sadtler, Kaitlyn Messing, Simon Gillette, William Esposito, Dominic |
description | The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attributed to particular forms of the protein. To improve the yield of these high-sensitivity forms of RBD and support the increased demand for this antigen in serology assays, we investigated several protein expression variables including DNA elements such as promoters and signal peptides, cell culture expression parameters, and purification processes. Through this investigation, we developed a simplified and robust purification strategy that consistently resulted in high levels of the high-sensitivity form of RBD and demonstrated that a carboxyterminal tag is responsible for the increased sensitivity in the ELISA. These improved reagents and processes produce high-quality proteins which are functional in serology assays and can be used to investigate seropositivity to SARS-CoV-2 infection. Highlights: Improved yields of SARS-CoV-2 spike RBD through modification of DNA constructs and purification parametersTwo versions of RBD show different sensitivity in serology assaysYields of greater than 50 mg/l obtained under optimal conditionsMagnetic bead purification technology improves throughput of protein production. |
doi_str_mv | 10.1101/2020.11.18.388868 |
format | article |
fullrecord | <record><control><sourceid>proquest_COVID</sourceid><recordid>TN_cdi_proquest_journals_2507164130</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2507164130</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1828-104445ac0fff23a250dbd77d1563134e2d1df9752c99bf25ce1b1949dba7a8a63</originalsourceid><addsrcrecordid>eNo1kM9LwzAcxYMgbsz9AV4k4EUPmfkmbZMc5_w1GAibCp5K2iSjc21q0gr77604T-8dHp_HewhdAJ0BULhllP26GcgZl1Jm8gSNWaYYkYymIzSNcUcpZSoDLpIzNOKc8YyCGKOPZd0G_20NHsT0ZVf5BnuHN_P1hiz8O2E4ttWnxcGWtu18IEXVmKrZYuNrXTX4en13f4OdDzja4Pd-e8A6Rn2I5-jU6X2006NO0Nvjw-vimaxenpaL-Yq0IJkkQJMkSXVJnXOMa5ZSUxghDKQZB55YZsA4JVJWKlU4lpYWClCJMoUWWuqMT9DVH3cY8NXb2OU734dmqMwHmIAsAU6H1OUx1Re1NXkbqlqHQ_7_BP8B9VVdQA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2507164130</pqid></control><display><type>article</type><title>Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays</title><source>Coronavirus Research Database</source><creator>Mehalko, Jennifer ; Drew, Matthew ; Snead, Kelly ; Denson, John-Paul ; Wall, Vanessa ; Taylor, Troy ; Sadtler, Kaitlyn ; Messing, Simon ; Gillette, William ; Esposito, Dominic</creator><creatorcontrib>Mehalko, Jennifer ; Drew, Matthew ; Snead, Kelly ; Denson, John-Paul ; Wall, Vanessa ; Taylor, Troy ; Sadtler, Kaitlyn ; Messing, Simon ; Gillette, William ; Esposito, Dominic</creatorcontrib><description>The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attributed to particular forms of the protein. To improve the yield of these high-sensitivity forms of RBD and support the increased demand for this antigen in serology assays, we investigated several protein expression variables including DNA elements such as promoters and signal peptides, cell culture expression parameters, and purification processes. Through this investigation, we developed a simplified and robust purification strategy that consistently resulted in high levels of the high-sensitivity form of RBD and demonstrated that a carboxyterminal tag is responsible for the increased sensitivity in the ELISA. These improved reagents and processes produce high-quality proteins which are functional in serology assays and can be used to investigate seropositivity to SARS-CoV-2 infection. Highlights: Improved yields of SARS-CoV-2 spike RBD through modification of DNA constructs and purification parametersTwo versions of RBD show different sensitivity in serology assaysYields of greater than 50 mg/l obtained under optimal conditionsMagnetic bead purification technology improves throughput of protein production.</description><identifier>EISSN: 2692-8205</identifier><identifier>DOI: 10.1101/2020.11.18.388868</identifier><identifier>PMID: 33236017</identifier><language>eng</language><publisher>United States: Cold Spring Harbor Laboratory Press</publisher><subject>Affinity chromatography ; Antigens ; Cell culture ; Chromatography ; Deoxyribonucleic acid ; DNA ; Enzyme-linked immunosorbent assay ; Gel electrophoresis ; Investigations ; Metal ions ; Molecular weight ; Polyacrylamide ; Protein purification ; Proteins ; Serology ; Severe acute respiratory syndrome coronavirus 2 ; Signal peptides ; Sodium lauryl sulfate ; Spike protein ; Streptavidin</subject><ispartof>bioRxiv, 2020-11</ispartof><rights>2020. This article is published under https://creativecommons.org/publicdomain/zero/1.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2507164130?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>780,784,27925,38516,43895</link.rule.ids><linktorsrc>$$Uhttps://www.proquest.com/docview/2507164130?pq-origsite=primo$$EView_record_in_ProQuest$$FView_record_in_$$GProQuest$$Hfree_for_read</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33236017$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mehalko, Jennifer</creatorcontrib><creatorcontrib>Drew, Matthew</creatorcontrib><creatorcontrib>Snead, Kelly</creatorcontrib><creatorcontrib>Denson, John-Paul</creatorcontrib><creatorcontrib>Wall, Vanessa</creatorcontrib><creatorcontrib>Taylor, Troy</creatorcontrib><creatorcontrib>Sadtler, Kaitlyn</creatorcontrib><creatorcontrib>Messing, Simon</creatorcontrib><creatorcontrib>Gillette, William</creatorcontrib><creatorcontrib>Esposito, Dominic</creatorcontrib><title>Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays</title><title>bioRxiv</title><addtitle>bioRxiv</addtitle><description>The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attributed to particular forms of the protein. To improve the yield of these high-sensitivity forms of RBD and support the increased demand for this antigen in serology assays, we investigated several protein expression variables including DNA elements such as promoters and signal peptides, cell culture expression parameters, and purification processes. Through this investigation, we developed a simplified and robust purification strategy that consistently resulted in high levels of the high-sensitivity form of RBD and demonstrated that a carboxyterminal tag is responsible for the increased sensitivity in the ELISA. These improved reagents and processes produce high-quality proteins which are functional in serology assays and can be used to investigate seropositivity to SARS-CoV-2 infection. Highlights: Improved yields of SARS-CoV-2 spike RBD through modification of DNA constructs and purification parametersTwo versions of RBD show different sensitivity in serology assaysYields of greater than 50 mg/l obtained under optimal conditionsMagnetic bead purification technology improves throughput of protein production.</description><subject>Affinity chromatography</subject><subject>Antigens</subject><subject>Cell culture</subject><subject>Chromatography</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Gel electrophoresis</subject><subject>Investigations</subject><subject>Metal ions</subject><subject>Molecular weight</subject><subject>Polyacrylamide</subject><subject>Protein purification</subject><subject>Proteins</subject><subject>Serology</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Signal peptides</subject><subject>Sodium lauryl sulfate</subject><subject>Spike protein</subject><subject>Streptavidin</subject><issn>2692-8205</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><recordid>eNo1kM9LwzAcxYMgbsz9AV4k4EUPmfkmbZMc5_w1GAibCp5K2iSjc21q0gr77604T-8dHp_HewhdAJ0BULhllP26GcgZl1Jm8gSNWaYYkYymIzSNcUcpZSoDLpIzNOKc8YyCGKOPZd0G_20NHsT0ZVf5BnuHN_P1hiz8O2E4ttWnxcGWtu18IEXVmKrZYuNrXTX4en13f4OdDzja4Pd-e8A6Rn2I5-jU6X2006NO0Nvjw-vimaxenpaL-Yq0IJkkQJMkSXVJnXOMa5ZSUxghDKQZB55YZsA4JVJWKlU4lpYWClCJMoUWWuqMT9DVH3cY8NXb2OU734dmqMwHmIAsAU6H1OUx1Re1NXkbqlqHQ_7_BP8B9VVdQA</recordid><startdate>20201118</startdate><enddate>20201118</enddate><creator>Mehalko, Jennifer</creator><creator>Drew, Matthew</creator><creator>Snead, Kelly</creator><creator>Denson, John-Paul</creator><creator>Wall, Vanessa</creator><creator>Taylor, Troy</creator><creator>Sadtler, Kaitlyn</creator><creator>Messing, Simon</creator><creator>Gillette, William</creator><creator>Esposito, Dominic</creator><general>Cold Spring Harbor Laboratory Press</general><scope>NPM</scope><scope>8FE</scope><scope>8FH</scope><scope>AAFGM</scope><scope>AAMXL</scope><scope>ABOIG</scope><scope>ABUWG</scope><scope>ADZZV</scope><scope>AFKRA</scope><scope>AFLLJ</scope><scope>AFOLM</scope><scope>AGAJT</scope><scope>AQTIP</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQCXX</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20201118</creationdate><title>Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays</title><author>Mehalko, Jennifer ; Drew, Matthew ; Snead, Kelly ; Denson, John-Paul ; Wall, Vanessa ; Taylor, Troy ; Sadtler, Kaitlyn ; Messing, Simon ; Gillette, William ; Esposito, Dominic</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1828-104445ac0fff23a250dbd77d1563134e2d1df9752c99bf25ce1b1949dba7a8a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Affinity chromatography</topic><topic>Antigens</topic><topic>Cell culture</topic><topic>Chromatography</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Gel electrophoresis</topic><topic>Investigations</topic><topic>Metal ions</topic><topic>Molecular weight</topic><topic>Polyacrylamide</topic><topic>Protein purification</topic><topic>Proteins</topic><topic>Serology</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Signal peptides</topic><topic>Sodium lauryl sulfate</topic><topic>Spike protein</topic><topic>Streptavidin</topic><toplevel>online_resources</toplevel><creatorcontrib>Mehalko, Jennifer</creatorcontrib><creatorcontrib>Drew, Matthew</creatorcontrib><creatorcontrib>Snead, Kelly</creatorcontrib><creatorcontrib>Denson, John-Paul</creatorcontrib><creatorcontrib>Wall, Vanessa</creatorcontrib><creatorcontrib>Taylor, Troy</creatorcontrib><creatorcontrib>Sadtler, Kaitlyn</creatorcontrib><creatorcontrib>Messing, Simon</creatorcontrib><creatorcontrib>Gillette, William</creatorcontrib><creatorcontrib>Esposito, Dominic</creatorcontrib><collection>PubMed</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>bioRxiv</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Mehalko, Jennifer</au><au>Drew, Matthew</au><au>Snead, Kelly</au><au>Denson, John-Paul</au><au>Wall, Vanessa</au><au>Taylor, Troy</au><au>Sadtler, Kaitlyn</au><au>Messing, Simon</au><au>Gillette, William</au><au>Esposito, Dominic</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays</atitle><jtitle>bioRxiv</jtitle><addtitle>bioRxiv</addtitle><date>2020-11-18</date><risdate>2020</risdate><eissn>2692-8205</eissn><abstract>The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attributed to particular forms of the protein. To improve the yield of these high-sensitivity forms of RBD and support the increased demand for this antigen in serology assays, we investigated several protein expression variables including DNA elements such as promoters and signal peptides, cell culture expression parameters, and purification processes. Through this investigation, we developed a simplified and robust purification strategy that consistently resulted in high levels of the high-sensitivity form of RBD and demonstrated that a carboxyterminal tag is responsible for the increased sensitivity in the ELISA. These improved reagents and processes produce high-quality proteins which are functional in serology assays and can be used to investigate seropositivity to SARS-CoV-2 infection. Highlights: Improved yields of SARS-CoV-2 spike RBD through modification of DNA constructs and purification parametersTwo versions of RBD show different sensitivity in serology assaysYields of greater than 50 mg/l obtained under optimal conditionsMagnetic bead purification technology improves throughput of protein production.</abstract><cop>United States</cop><pub>Cold Spring Harbor Laboratory Press</pub><pmid>33236017</pmid><doi>10.1101/2020.11.18.388868</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | EISSN: 2692-8205 |
ispartof | bioRxiv, 2020-11 |
issn | 2692-8205 |
language | eng |
recordid | cdi_proquest_journals_2507164130 |
source | Coronavirus Research Database |
subjects | Affinity chromatography Antigens Cell culture Chromatography Deoxyribonucleic acid DNA Enzyme-linked immunosorbent assay Gel electrophoresis Investigations Metal ions Molecular weight Polyacrylamide Protein purification Proteins Serology Severe acute respiratory syndrome coronavirus 2 Signal peptides Sodium lauryl sulfate Spike protein Streptavidin |
title | Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A17%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_COVID&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improved%20production%20of%20SARS-CoV-2%20spike%20receptor-binding%20domain%20(RBD)%20for%20serology%20assays&rft.jtitle=bioRxiv&rft.au=Mehalko,%20Jennifer&rft.date=2020-11-18&rft.eissn=2692-8205&rft_id=info:doi/10.1101/2020.11.18.388868&rft_dat=%3Cproquest_COVID%3E2507164130%3C/proquest_COVID%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p1828-104445ac0fff23a250dbd77d1563134e2d1df9752c99bf25ce1b1949dba7a8a63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2507164130&rft_id=info:pmid/33236017&rfr_iscdi=true |